Related Articles
Mirova's annual market review and 2024 outlook for private assets.
Mirova's annual market review and 2024 outlook for listed assets.
Compelling AI applications, renewable energy recovery, and pharma developments are considered for 2024 by Jens Peers.
From a recession to AI, portfolio managers share diverse views on the big topics shaping investment decisions in 2024.